Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated-dose LSD microdosing study
NL-OMON22020Recruiting
- Sponsor
- Maastricht University
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of Lysergide (2 arms), sponsored by Maastricht University. Primary endpoint: Positive mood and positive subjective effects. Started Feb 2020; status: recruiting.
02
Drugs
Lysergide
Beyond the preview
Go deeper on NL-OMON22020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22020.